Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Efficiency, Organizational | 1 | 2002 | 13 | 0.190 |
Why?
|
| Task Performance and Analysis | 1 | 2002 | 43 | 0.190 |
Why?
|
| Professional Competence | 1 | 2002 | 37 | 0.190 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 76 | 0.180 |
Why?
|
| Faculty, Medical | 1 | 2002 | 55 | 0.180 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 13 | 0.180 |
Why?
|
| Primary Prevention | 1 | 2001 | 25 | 0.170 |
Why?
|
| Immunization | 1 | 2001 | 120 | 0.170 |
Why?
|
| Education, Medical | 1 | 2000 | 67 | 0.160 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2017 | 1 | 0.140 |
Why?
|
| Hot Flashes | 1 | 2017 | 6 | 0.140 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2017 | 26 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2018 | 115 | 0.140 |
Why?
|
| Menopause | 1 | 2017 | 30 | 0.130 |
Why?
|
| Primary Health Care | 1 | 2018 | 152 | 0.130 |
Why?
|
| Oklahoma | 4 | 2018 | 1005 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 367 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 30 | 0.110 |
Why?
|
| Influenza, Human | 3 | 1991 | 85 | 0.110 |
Why?
|
| Medicaid | 1 | 2014 | 54 | 0.110 |
Why?
|
| Program Evaluation | 2 | 2018 | 167 | 0.080 |
Why?
|
| Rimantadine | 1 | 1988 | 1 | 0.070 |
Why?
|
| Adamantane | 1 | 1988 | 4 | 0.070 |
Why?
|
| Quality of Health Care | 2 | 2018 | 81 | 0.060 |
Why?
|
| Adult | 5 | 2018 | 7765 | 0.060 |
Why?
|
| Middle Aged | 3 | 2018 | 7164 | 0.050 |
Why?
|
| Humans | 8 | 2018 | 28167 | 0.050 |
Why?
|
| Employee Performance Appraisal | 1 | 2002 | 5 | 0.050 |
Why?
|
| Relative Value Scales | 1 | 2002 | 7 | 0.050 |
Why?
|
| Program Development | 1 | 2002 | 77 | 0.050 |
Why?
|
| United States | 2 | 2014 | 2151 | 0.050 |
Why?
|
| Viral Vaccines | 1 | 2001 | 13 | 0.040 |
Why?
|
| Health Care Rationing | 1 | 2000 | 5 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 2001 | 29 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2001 | 39 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2001 | 58 | 0.040 |
Why?
|
| Faculty | 1 | 2000 | 62 | 0.040 |
Why?
|
| Aged | 2 | 2018 | 5416 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 2018 | 15 | 0.040 |
Why?
|
| Health Services Research | 1 | 2018 | 43 | 0.040 |
Why?
|
| Serotonin | 1 | 2017 | 16 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2017 | 32 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 118 | 0.030 |
Why?
|
| Health Promotion | 1 | 2018 | 176 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 296 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 386 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2014 | 104 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2021 | 0.030 |
Why?
|
| Female | 3 | 2018 | 15191 | 0.020 |
Why?
|
| Antibodies, Heterophile | 1 | 1991 | 3 | 0.020 |
Why?
|
| Child, Preschool | 3 | 1991 | 1149 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 1991 | 417 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2738 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 1991 | 51 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1991 | 79 | 0.020 |
Why?
|
| Influenza A virus | 1 | 1991 | 33 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 1991 | 42 | 0.020 |
Why?
|
| Family | 1 | 1989 | 98 | 0.020 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1988 | 15 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 1988 | 37 | 0.020 |
Why?
|
| Child | 3 | 1991 | 2253 | 0.020 |
Why?
|
| Infant | 2 | 1989 | 1014 | 0.020 |
Why?
|
| Adolescent | 3 | 1991 | 3128 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1988 | 215 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1989 | 219 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 1988 | 1015 | 0.020 |
Why?
|
| Male | 2 | 2018 | 13510 | 0.010 |
Why?
|
| Risk Factors | 1 | 1988 | 2087 | 0.010 |
Why?
|
| Vaccines, Inactivated | 1 | 1991 | 4 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 1991 | 7 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1991 | 248 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1989 | 6 | 0.000 |
Why?
|
| Influenza B virus | 1 | 1989 | 3 | 0.000 |
Why?
|
| Social Adjustment | 1 | 1989 | 11 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1989 | 21 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1989 | 74 | 0.000 |
Why?
|
| Age Factors | 1 | 1991 | 733 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1989 | 889 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1989 | 1257 | 0.000 |
Why?
|